Copyright
©2010 Baishideng Publishing Group Co.
World J Gastroenterol. Sep 21, 2010; 16(35): 4436-4442
Published online Sep 21, 2010. doi: 10.3748/wjg.v16.i35.4436
Published online Sep 21, 2010. doi: 10.3748/wjg.v16.i35.4436
Variable | Group A (intraluminal brachytherapy) (n = 17) | Group B (control arm) (n = 19) |
Median age (yr) | 34.7 (range 17-55) | 34.7 (range 17-55) |
Gender | ||
Male | 13 (76.5) | 14 (73.7) |
Women | 4 (23.5) | 5 (26.3) |
Site of primary tumor | ||
Upper rectum | 8 (47.1) | 9 (47.4) |
Lower rectum | 9 (52.9) | 10 (52.6) |
Clinical/radiological stage | ||
T2 N+ | 1 (5.9) | 1 (5.3) |
T3 N0 | 2 (11.8) | 3 (15.8) |
T3 N+ | 7 (41.1) | 8 (42.1) |
T4 N0 | 5 (29.4) | 6 (31.5) |
T4 N+ | 2 (11.8) | 1 (5.3) |
Performance status (ECOG) | ||
0 | 13 (76.5) | 12 (63.2) |
1 | 4 (23.5) | 7 (36.8) |
- Citation: Tunio MA, Rafi M, Hashmi A, Mohsin R, Qayyum A, Hasan M, Sattar A, Mubarak M. High-dose-rate intraluminal brachytherapy during preoperative chemoradiation for locally advanced rectal cancers. World J Gastroenterol 2010; 16(35): 4436-4442
- URL: https://www.wjgnet.com/1007-9327/full/v16/i35/4436.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i35.4436